Stock Earnings

Question 1

Teva Pharmaceutical Industries Limited'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Teva Pharmaceutical Industries Limited'in toplam varlıkları $0 olup, net 損失 $0'dir.

Question 2

TEVA'ün temel finansal oranları nelerdir?

Accepted Answer

Teva Pharmaceutical Industries Limited'in cari oranı 0, net kâr marjı 0, hisse başına satış $0'dir.

Question 3

Teva Pharmaceutical Industries Limited'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Teva Pharmaceutical Industries Limited 最大收入來源為 Generics, Innovative Medicines and Biopharmaceuticals，在最近的收益報告中收入為 61,240,545,677。就地區而言，United States 是 Teva Pharmaceutical Industries Limited 的主要市場，收入為 29,739,273,692。

Question 4

Teva Pharmaceutical Industries Limited kârlı mı?

Accepted Answer

無, son mali tablolara göre Teva Pharmaceutical Industries Limited'in net 損失 $0'dir.

Question 5

Teva Pharmaceutical Industries Limited'in herhangi bir yükümlülüğü var mı?

Accepted Answer

無, Teva Pharmaceutical Industries Limited'in yükümlülüğü 0'dir.

Question 6

Teva Pharmaceutical Industries Limited'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Teva Pharmaceutical Industries Limited'in toplam tedavüldeki hisse sayısı 0'dir.

Breakdown	TTM	12/31/2025	09/30/2025	06/30/2025	03/31/2025	12/31/2024
營收	17,258	4,711	4,480	4,176	3,891	4,229
營收年增率 (YoY)	4%	11%	3%	0%	2%	-5%
營收成本	8,160	2,037	2,125	2,021	1,977	2,042
毛利	9,098	2,674	2,355	2,155	1,914	2,187
銷售、一般及管理費用	3,971	1,120	973	959	919	952
研發	1,014	267	256	244	247	247
營業費用	4,940	1,369	1,235	1,207	1,129	1,222
其他非營業收入 (費用)	-17	72	-27	-49	-13	93
稅前淨利	1,223	80	646	203	294	-247
所得稅費用	-180	-390	214	-78	74	28
淨利	1,409	480	433	282	214	-217
淨利成長	-186%	-321%	-199%	-133%	-254%	-151%
稀釋後流通股數	1,172	1,172	1,164	1,161	1,138	1,134
股數年變動 (YoY)	3%	3%	3%	2%	1%	1%
每股盈餘 (稀釋)	1.21	0.4	0.37	0.24	0.18	-0.19
每股盈餘成長率	-184%	-314%	-196%	-133%	-252%	-150%
自由現金流	1,148	1,016	233	131	-232	446
每股自由現金流	--	--	--	--	--	--
毛利率	52.71%	56.76%	52.56%	51.6%	49.19%	51.71%
營業利益率	24.09%	27.7%	25%	22.7%	20.17%	22.81%
淨利率	8.16%	10.18%	9.66%	6.75%	5.49%	-5.13%
自由現金流利潤率	6.65%	21.56%	5.2%	3.13%	-5.96%	10.54%
EBITDA	5,160	1,565	1,368	1,198	1,029	1,234
EBITDA 利潤率	29.89%	33.22%	30.53%	28.68%	26.44%	29.17%
EBITDA 中的折舊與攤銷	1,002	260	248	250	244	269
EBIT	4,158	1,305	1,120	948	785	965
EBIT 利潤率	24.09%	27.7%	25%	22.7%	20.17%	22.81%
有效稅率	-14.71%	-487.5%	33.12%	-38.42%	25.17%	-11.33%

Teva Pharmaceutical Industries Limited (TEVA) 財務

TEVA 股價走勢圖

關鍵數據

前收市價

開盤價

當日範圍

52週區間

交易量

平均成交量

股息收益率

每股盈餘 (TTM)

市值

什麼是 Teva Pharmaceutical Industries ？

TEVA 收入

Follow-Up Questions